Drug
Tafasitamab And Lenalidomide
Tafasitamab And Lenalidomide: highest development phase Phase 2, developed by InnoCare Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- InnoCare Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tafasitamab and Lenalidomide NCT05552937 | Phase 2 | DLBCL |
Latest
No recent events.
Follow Tafasitamab And Lenalidomide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.